Artiva, Merck to develop CAR NK cell therapies
Artiva Biotherapeutics and Merck have signed an agreement to develop chimeric antigen receptor (CAR) natural killer (NK) cell therapeutics for solid tumors. Read More
Exothera adds continuous upstream bioprocessing tech to services
Contract development and manufacturing organization Exothera has acquired the NevoLine Upstream manufacturing platform, the latest equipment available from Univercells Technologies. Read More
Bio-Techne invests in China-based cell and gene therapy media company
Bio-Techne has made an initial minority strategic equity investment in Changzhou Eminence Biotechnology. The companies will synergistically work on the development and commercialization of good manufacturing practice molecules and proteins for cell and gene therapy media. Read More
Provention Bio's bispecific antibody boosts gene therapy safety in mice
Provention Bio has released results from a preclinical proof-of-concept study for its bispecific antibody-based molecule, PRV-3279, conducted in mouse models for Pompe disease. Read More
AskBio adds 2 neurodegenerative gene therapy programs to pipeline
The clinical team from Brain Neurotherapy Bio, an Ohio-based gene therapy company, has joined Asklepios BioPharmaceutical (AskBio), a Bayer company, to expand its clinical pipeline for the treatment of neurodegenerative disorders. Read More
PerkinElmer debuts test kit to expand GPCR therapies
PerkinElmer has debuted new assay kits to help further G protein-coupled receptor (GPCR) drug discovery. Read More
Thermo Fisher introduces cell therapy workflow media
Thermo Fisher Scientific has launched a new medium of the first human T lymphocytes (T cells) specifically designed for allogeneic cell therapy workflows. Read More
Ajinomoto to up production of Humanigen's COVID-19 drug
Ajinomoto Bio-Pharma Services and Humanigen are expanding their manufacturing agreement for the fill-finish supply of lenzilumab, an investigational COVID-19 drug. Read More
Cognate, Nucleus Biologics partner on cell, gene therapy media
Contract development and manufacturing organization Cognate BioServices and Nucleus Biologics have partnered to provide custom and commercial medias and delivery systems for cell and gene therapy clients. Read More
BioArctic awarded patent by EPO for potential Alzheimer's antibodies
The European Patent Office (EPO) has granted Swedish-based biopharmaceutical company BioArctic patent EP 2, 558, 968 B1 for its novel antibodies that could be developed to treat Alzheimer's disease. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
